로켓 파마슈티컬스, Inc.
DE ˙ DB ˙ US77313F1066
€2.44 0.00 (0.00%)
2026-06-04
주가
SecurityDE:9IP1 / Rocket Pharmaceuticals, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership5,107,708 shares
Latest Disclosed Value $ 18,285,595
Citigroup Inc ownership in 9IP1 / Rocket Pharmaceuticals, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 5,107,708 shares of Rocket Pharmaceuticals, Inc. (DE:9IP1) valued at $14,378,198 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 5,246,349 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of -2.64% during the quarter. The current value of the position is $12,462,808 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (9IP1) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:9IP1 / Rocket Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 5,107,708 -138,641 -2.64 18,286 -0.70 0.0078
2026-02-13 2025-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 5,246,349 5,235,924 50,224.69 18,415 55,700.00 0.0081
2025-11-10 2025-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 10,425 -137,604 -92.96 34 -90.88 0.0000
2025-08-11 2025-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 148,029 -86,149 -36.79 363 -76.81 0.0002
2025-05-12 2025-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 234,178 110,763 89.75 1,562 0.64 0.0008
2025-02-12 2024-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 123,415 71,919 139.66 1,551 63.09 0.0009
2024-11-12 2024-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 51,496 17,406 51.06 951 29.74 0.0006
2024-08-12 2024-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 34,090 -251,053 -88.04 734 -90.46 0.0005
2024-05-10 2024-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 285,143 194,889 215.93 7,682 184.06 0.0050
2024-02-09 2023-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 90,254 -70,861 -43.98 2,705 -18.09 0.0019
2023-12-06 2023-09-30 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 161,115 75,071 87.25 3,301 93.15 0.0025
2023-11-09 2023-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 161,115 75,071 3,301 0.0010
2023-08-10 2023-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 86,044 -163,726 -65.55 1,710 -60.05 0.0011
2023-05-11 2023-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 249,770 115,216 85.63 4,279 62.48 0.0030
2023-02-09 2022-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 134,554 -202,411 -60.07 2,633 -51.04 0.0021
2022-11-10 2022-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 336,965 -71,830 -17.57 5,378 -4.39 0.0038
2022-08-10 2022-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 408,795 363,367 799.87 5,625 680.17 0.0042
2022-05-12 2022-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 45,428 -93,377 -67.27 721 -76.20 0.0004
2022-02-10 2021-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 138,805 57,676 71.09 3,030 24.95 0.0016
2021-11-10 2021-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 81,129 -30,872 -27.56 2,425 -51.11 0.0014
2021-08-10 2021-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 112,001 25,461 29.42 4,960 29.17 0.0030
2021-05-13 2021-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 86,540 74,121 596.84 3,840 463.88 0.0025
2021-02-11 2020-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 12,419 7,715 164.01 681 530.56 0.0004
2020-11-12 2020-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 4,704 -22,927 -82.98 108 -81.31 0.0001
2020-08-12 2020-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 27,631 5,506 24.89 578 87.06 0.0005
2020-05-12 2020-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 22,125 3,070 16.11 309 -28.80 0.0003
2020-02-12 2019-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 19,055 -4,235 -18.18 434 60.15 0.0003
2019-11-08 2019-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 23,290 -31,873 -57.78 271 -67.23 0.0002
2019-08-12 2019-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 55,163 48,396 715.18 827 594.96 0.0007
2019-05-13 2019-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 6,767 4 0.06 119 19.00 0.0001
2019-02-12 2018-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 6,763 -319 -4.50 100 -42.53 0.0001
2018-11-13 2018-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 7,082 2,397 51.16 174 89.13 0.0002
2018-08-10 2018-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 4,685 4,685 92 0.0001
2017-11-13 2017-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 0 -1 -100.00 0 0.0000
2017-08-11 2017-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 1 -180 -99.45 0 0.0000
2017-05-12 2017-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 181 169 1,408.33 0 0.0000
2017-02-10 2016-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 12 12 0 0.0000
2016-11-10 2016-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 0 -4,909 -100.00 0 -100.00
2016-08-12 2016-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 4,909 1,577 47.33 37 48.00 0.0000
2016-05-13 2016-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 3,332 -362 -9.80 25 -40.48 0.0000
2016-02-12 2015-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 3,694 3,694 0.00 42 0.0000
2015-11-13 2015-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 0 -600 -100.00 0 -100.00
2015-08-13 2015-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 600 -3,200 -84.21 3 -85.71 0.0000
2015-05-14 2015-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 3,800 3,800 21 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-11 2025-06-30 13F ROCKET PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-12 2025-03-31 13F ROCKET PHARMACEUTICALS COM Call 59,900 400 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-11 2025-06-30 13F ROCKET PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-12 2025-03-31 13F ROCKET PHARMACEUTICALS COM Put 59,900 400 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.